Aveanna Healthcare Holdings (AVAH) Earnings Analysis
Aveanna Healthcare Holdings (AVAH) next reports earnings on 2026-08-06, consensus EPS 0.17 USD. Last quarter (2026-05-14) it beat with EPS 0.18 USD vs 0.13 USD est (+38.5%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 7.44.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVAH next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.17 USD |
| Revenue estimate | 0.64B |
AVAH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 0.18 USD | 0.13 USD | +38.5% | Beat |
| 2026-03-19 | 0.17 USD | 0.1538 USD | +10.5% | Beat |
| 2025-11-06 | 0.15 USD | 0.08 USD | +87.5% | Beat |
| 2025-08-07 | 0.18 USD | 0.04 USD | +350% | Beat |
| 2025-03-13 | 0.05 USD | 0.00391 USD | +1178.8% | Beat |
Beat rate: 5/5 (100%) over reported quarters with consensus data.
AVAH valuation and analyst view
| Trailing P/E | 7.44 |
|---|---|
| Trailing EPS | 1.219 USD |
| Price / book | 8.43 |
| Dividend yield | 0.00% |
| Market cap | 2.06B |
| Analyst consensus | Buy (7 buy / 4 hold / 1 sell) |
| Avg price target | 9.9 USD |
Related research pages
Frequently asked questions
When is Aveanna Healthcare Holdings (AVAH)'s next earnings date?
Aveanna Healthcare Holdings is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.17 USD and revenue estimate of 0.64B.
Did AVAH beat earnings last quarter?
In its 2026-05-14 report, AVAH posted EPS of 0.18 USD versus a 0.13 USD estimate — a beat of 38.5%.
What is AVAH's earnings track record?
Over the last 5 reported quarters with consensus data, AVAH beat estimates 5 times (100%).
What is AVAH's current P/E ratio and EPS?
AVAH trades at a trailing P/E of 7.44 on trailing EPS of 1.2185465644586313 USD.
What do analysts rate AVAH?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 7 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 9.9 USD.